Related Experiment Video
Updated: Jun 28, 2026
Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation
Published on: December 31, 2007
Interview: glycolipid antigen presentation by CD1d and the therapeutic potential of NKT cell activation
1Department of Developmental Immunology, La Jolla Institute of Allergy and Immunology, USA.
Abstract:
Natural Killer T cells (NKT) are critical determinants of the immune response to cancer, regulation of autioimmune disease, clearance of infectious agents, and the development of artheriosclerotic plaques. In this interview, Mitch Kronenberg discusses his laboratory's efforts to understand the mechanism through which NKT cells are activated by glycolipid antigens. Central to these studies is CD1d--the antigen presenting molecule that presents glycolipids to NKT cells. The advent of CD1d tetramer technology, a technique developed by the Kronenberg lab, is critical for the sorting and identification of subsets of specific glycolipid-reactive T cells. Mitch explains how glycolipid agonists are being used as therapeutic agents to activate NKT cells in cancer patients and how CD1d tetramers can be used to assess the state of the NKT cell population in vivo following glycolipid agonist therapy. Current status of ongoing clinical trials using these agonists are discussed as well as Mitch's prediction for areas in the field of immunology that will have emerging importance in the near future.
Insights
Natural Killer T (NKT) cells are key to immune responses. Research explores how glycolipid antigens activate NKT cells via CD1d molecules, using CD1d tetramer technology for therapeutic insights.
Area of Science:
- Immunology
- Cellular Biology
- Cancer Research
Background:
- Natural Killer T (NKT) cells play a crucial role in immune responses, including cancer immunity, autoimmune disease regulation, and infectious agent clearance.
- Understanding the activation mechanisms of NKT cells by glycolipid antigens is vital for developing novel immunotherapies.
Purpose of the Study:
- To elucidate the mechanisms of NKT cell activation by glycolipid antigens.
- To highlight the role of CD1d, the antigen-presenting molecule, in this process.
- To discuss the therapeutic applications of glycolipid agonists and CD1d tetramer technology in cancer treatment.
Main Methods:
- Utilizing CD1d tetramer technology for sorting and identifying specific glycolipid-reactive T cell subsets.
- Investigating the activation pathways of NKT cells by glycolipid antigens.
- Analyzing the in vivo status of NKT cell populations following glycolipid agonist therapy.
Main Results:
- CD1d is central to presenting glycolipids to NKT cells.
- CD1d tetramer technology enables precise identification and sorting of NKT cell subsets.
- Glycolipid agonists show therapeutic potential in activating NKT cells for cancer treatment.
Conclusions:
- NKT cell activation by glycolipid antigens, mediated by CD1d, offers promising therapeutic strategies for cancer.
- CD1d tetramer technology is a powerful tool for assessing NKT cell responses in vivo.
- Ongoing clinical trials and future directions in NKT cell immunology are discussed.
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:22T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
01:28Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
01:29Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...